Family premiums in employer-sponsored coverage grew by 7% in 2024, averaging $25,572, according to a new report from KFF. This makes 2024 the second straight year in which premiums increased by 7%, ...

KFF Biden era law improves Medicare Part D coverage for high-cost drugs ahead of 2026 price negotiations, enhancing patient access nationwide.

Despite the boom in popularity of expensive GLP-1 drugs to treat weight loss, fewer than one in five large employers are covering such prescriptions, a new KFF analysis shows. In this photo is Ozempic ...

It’s been a busy week at the FDA, with a political appointee overruling agency scientists to reject an application for a new flu vaccine. Meanwhile, anti-abortion Republicans on Capitol Hill complain ...

A new study shows that close to 53 million prior authorization requests were sent to Medicare Advantage (MA) plans in 2024, increasing from 2023 and far above the number required in traditional ...

The new Trump administration is likely to reduce subsidies for Affordable Care Act insurance plans and roll back Medicaid coverage. Public health authorities worry that antivaccine activist Robert F.